For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...

This is called, aptly, obstructive hypertrophic cardiomyopathy. This kind of obstruction is behind many of the more ...

For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...

A bounding pulse is when your heart beats strongly. You may feel your pulse in your neck, wrist, or foot. Here’s why it ...

Edgewise Therapeutics announced topline data from Phase 1 and Phase 2 trials of EDG-7500 for obstructive hypertrophic ...

It is used to replace the pumping action of the damaged heart ventricles while a person waits for a heart transplant. Other ...

Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD, discuss the use of beta-blocker therapy following acute MI ...

However, microscopic examination of heart tissue usually reveals that there are some abnormalities in the left ventricle as well. With ARVC, parts of your heart tissue become scarred and replaced ...

ARVC is a genetic condition of the heart muscle that can cause arrhythmias (abnormal heartbeats), heart failure, and sudden ...

Leerink Partners analyst Joseph Schwartz reiterated a Buy rating on Edgewise Therapeutics (EWTX – Research Report) today and set a price ...

Background Pregnant patients with single ventricle (SV) physiology carry a high risk of spontaneous pregnancy loss (SPL), yet the clinical factors contributing to this risk are not well defined.